×

Identification of an exogenous intra-erythrocytic bacterium in patients having systemic lupus erythematosus, and treatment

  • US 5,795,563 A
  • Filed: 12/13/1996
  • Issued: 08/18/1998
  • Est. Priority Date: 09/04/1996
  • Status: Expired due to Term
First Claim
Patent Images

1. A process for treating a patient whose erythrocytes contain exogenous bacterial structures stainable with acridine orange or giemsa and are visible in phase contrast microscopy that comprises administering to said patient an antibacterial amount of a rifamycin plus an antibacterial amount of a macrolide or a third generation cephalosporin until said exogenous bacterial structures are absent from the erythrocytes.

View all claims
  • 1 Assignment
Timeline View
Assignment View
    ×
    ×